Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment.

[1]  M. Gómez-Sánchez,et al.  Pulmonary hypertension due to toxic oil syndrome. A clinicopathologic study. , 1989, Chest.

[2]  P. Vanhoutte.  The endothelium--modulator of vascular smooth-muscle tone. , 1988, The New England journal of medicine.

[3]  B. Brundage,et al.  Pulmonary hypertension from chronic pulmonary thromboembolism. , 1988, Annals of internal medicine.

[4]  Edwards Wd.  Pathology of pulmonary hypertension. , 1988, Cardiovascular clinics.

[5]  W. Williams,et al.  Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. , 1987, Circulation.

[6]  D. G. Ritter,et al.  Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. , 1987, Circulation.

[7]  B. Brundage,et al.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. , 1987, Circulation.

[8]  W. Williams,et al.  Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[9]  B. Brundage,et al.  Antinuclear antibodies in primary pulmonary hypertension. , 1986, Journal of the American College of Cardiology.

[10]  B. Brundage,et al.  Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. , 1986, Annals of internal medicine.

[11]  T. Takahashi,et al.  Pulmonary vascular disease in secundum atrial septal defect with pulmonary hypertension. , 1986, Chest.

[12]  R. Us.  The endothelial surface and responses to injury. , 1986 .

[13]  T. Takahashi,et al.  Pulmonary veno-occlusive disease: involvement of pulmonary arteries and review of the literature. , 1985, Human pathology.

[14]  S. Gray,et al.  Endothelium-Dependent Reactivity in Resistance Vessels , 1985 .

[15]  M. Peach,et al.  Endothelium‐Derived Vascular Relaxing Factor , 1985, Hypertension.

[16]  Gurtner Hp.  Aminorex and pulmonary hypertension. A review. , 1985 .

[17]  F. Khaja,et al.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. , 1985, Annals of internal medicine.

[18]  W. Edwards,et al.  Primary pulmonary hypertension: a histopathologic study of 80 cases. , 1985, Mayo Clinic proceedings.

[19]  V. Fuster,et al.  Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.

[20]  K. Mcintyre,et al.  Clinical and hemodynamic correlates in pulmonary embolism. , 1984, Clinics in chest medicine.

[21]  J. Reeves,et al.  Plexogenic pulmonary hypertension of unknown origin. What's new? , 1984, Clinical science.

[22]  M. Fukase,et al.  Vascular Lesions In Systemic Lupus Erythematosus (Sle) With Pulmonary Hypertension , 1984, Acta pathologica japonica.

[23]  J. F. Wolfe,et al.  A Prospective Evaluation Emphasizing Pulmonary Involvement in Patients with Mixed Connective Tissue Disease , 1984, Medicine.

[24]  G. Hutchins,et al.  Primary pulmonary hypertension and cirrhosis: are they related? , 2015, The American review of respiratory disease.

[25]  R. Furchgott.  Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.

[26]  J. A. Payne,et al.  Primary pulmonary hypertension after portocaval shunt. , 1983, Journal of clinical gastroenterology.

[27]  M. Heymann,et al.  Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. , 1981, Circulation.

[28]  C. Wagenvoort,et al.  Plexogenic pulmonary arteriopathy: significance of medial thickness with respect to advanced pulmonary vascular lesions. , 1981, The American journal of pathology.

[29]  J. M. Tabuenca.  TOXIC-ALLERGIC SYNDROME CAUSED BY INGESTION OF RAPESEED OIL DENATURED WITH ANILINE , 1981, The Lancet.

[30]  R. Furchgott.  The requirement for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators , 1981 .

[31]  L. Reid,et al.  Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. , 1980, The American journal of physiology.

[32]  L. Reid,et al.  Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. , 1979, The American journal of pathology.

[33]  J. Reeves,et al.  Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. , 1978, The American journal of cardiology.

[34]  J. Shaver,et al.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). , 1977, Annals of internal medicine.

[35]  C. Wagenvoort,et al.  Pathology of pulmonary hypertension , 1977 .

[36]  Fishman Ap.  State of the art: chronic cor pulmonale. , 1976 .

[37]  L. Reid,et al.  Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats. , 1974, British journal of experimental pathology.

[38]  E. W. Hancock,et al.  Regression of extreme pulmonary hypertension after mitral valve surgery. , 1972, The American journal of cardiology.

[39]  J. LeónCastro,et al.  [Primary pulmonary hypertension]. , 1971, Revista clinica espanola.

[40]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .

[41]  Cole Lb,et al.  An attack of tetanus. , 1968 .

[42]  G. T. Smith,et al.  QUANTITATIVE STUDIES OF PULMONARY EMBOLISM , 1964, The American journal of the medical sciences.

[43]  P. Wood.  PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTOR* , 1958, British heart journal.

[44]  D. Dresdale,et al.  Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance. , 1954, Bulletin of the New York Academy of Medicine.

[45]  D. Dresdale,et al.  Primary pulmonary hypertension. I. Clinical and hemodynamic study. , 1951, The American journal of medicine.